Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

Nav

General Info

Geography

United Kingdom (GBR)

Coverage type

Country

Time period covered

01/1988 - 12/1988

Data type

Scientific literature

Keywords

Ischemic heart disease

Citation

Authors

ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

Journal

Lancet

Volume

Issue

8607

Pages

349-60

Publication year

1988

Suggested citation

ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988; 2(8607): 349-60.

PMID

2899772

GHDx Entry last modified on: Mar 25, 2025

Header sites

Search form

Main menu

Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

Nav